The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Current Market Dynamics

• Market Size: The congestive heart failure treatment devices market grew from $18.22 billion in 2023 to $19.61 billion in 2024.
• Growth Rate: This represents a compound annual growth rate (CAGR) of 7.6%.
• Historical Drivers:
  • Shift towards less invasive surgical techniques.
  • Demand for minimally invasive structural heart devices.
  • Ongoing training and education programs for healthcare professionals.
  • Rising healthcare expenditure.
  • Growing patient preference for non-surgical or minimally invasive treatment options.

Read More On The Congestive Heart Failure Treatment Devices Market Report 2024 –
https://www.thebusinessresearchcompany.com/report/congestive-heart-failure-treatment-devices-global-market-report

Future Market Projections

• Projected Growth: The market is expected to grow to $26.57 billion by 2028.
• Forecast CAGR: Reflects a CAGR of 7.9%.
• Future Drivers:
  • Increasing aging population.
  • Growing awareness about heart health.
  • Implementation of screening programs.
  • Favorable reimbursement policies for structural heart procedures.
  • Timely regulatory approvals for new structural heart devices.

Impact of Cardiovascular Disorders

• Market Growth: The increasing prevalence of cardiovascular disorders is driving the expansion of the congestive heart failure treatment devices market.
• Cardiovascular Disorders:
  • Include coronary artery disease, hypertension, and heart failure.
  • Driven by factors such as obesity, sedentary lifestyles, poor diets, and aging populations.
• Role of CHF Devices: These devices are crucial in managing cardiovascular disorders by regulating heart rhythms and improving heart function, significantly enhancing patient outcomes.
• Example: In the UK, deaths due to heart attacks increased from 19,440 in 2020 to 20,061 in 2021, highlighting the growing need for effective CHF treatment devices.

Technological Innovation in CHF Treatment Devices

• Bluetooth-Enabled Pacemakers: Companies are developing pacemakers with Bluetooth connectivity to enhance remote monitoring and patient care.
  • Example: Microport Crm S.R.L. launched Alizea and Borea pacemakers in June 2021, featuring Bluetooth technology for remote monitoring, reducing the need for hospital visits, and supporting continuous patient follow-up.
  • Benefits: These pacemakers, with a projected lifespan of 13 years, include advanced features like safer mode and real-time electrogram (EGM), improving healthcare management.

Strategic Acquisitions in the Market

• Johnson & Johnson’s Acquisition of Abiomed Inc.: In December 2022, Johnson & Johnson acquired Abiomed Inc. for $16.6 billion.
  • Purpose: To expand its MedTech business into the cardiovascular device market, particularly in heart failure and recovery solutions.
  • Abiomed Inc.: A US-based manufacturer of congestive heart failure treatment devices.

Market Segmentation

• By Product:
  • Cardiac Pacemaker
  • Implantable Cardioverter Defibrillators (ICDs)
  • Cardiac Resynchronization Therapy Devices (CRT)
  • Counter Pulsation Devices
  • Ventricular Assist Devices (VADs)
• By Application:
  • Left Ventricular Assist Device (LVAD)
  • Right Ventricular Assist Device (RVAD)
  • Biventricular Assist Device (BIVAD)
• By End-User:
  • Hospitals and Clinics
  • Specialized Cardiovascular Disease Treatment Centers
  • Ambulatory Surgery Centers

Regional Insights

• North America: The largest region in the congestive heart failure treatment devices market in 2023.
• Asia-Pacific: Expected to be the fastest-growing region during the forecast period.

The congestive heart failure treatment devices market is set for continued growth, driven by increasing cardiovascular disorders, technological advancements, and strategic acquisitions. The market’s expansion is supported by a growing demand for minimally invasive solutions and the aging global population, positioning it for significant growth in the coming years.

Request for A Sample Of The Global Congestive Heart Failure Treatment Devices Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=15774&type=smp